Graves' disease: vizsgálatok itt: Spanyolország
9 of 10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Where
- Badalona, Barcelona, Córdoba, Granada, Madrid, Pamplona, Sevilla
- Életkor
- 18 év and over
- People
- 128 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to join2025-524001-33-00 - 2. fázisNot yet taking people in SpanyolországA Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Where
- Alcalá de Henares, Córdoba
- Életkor
- 18 év to 75 év
- People
- 60 worldwide
- Run by
- Biogen
See details and how to joinNCT07722546 · EU 2026-526482-19-00 - 3. fázisTaking peopleA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Alzira, Barcelona, Burjassot, Girona, Málaga, Móstoles, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - 2. fázisFut, nem toborozA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Madrid
- Életkor
- 18 év to 75 év
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - 1. fázisTaking peopleNEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Where
- A Coruna, Barcelona, Madrid, Málaga, Santander, Sevilla, Valencia
- Életkor
- 18 év to 65 év
- People
- 100 worldwide
- Run by
- Merida Biosciences
See details and how to joinNCT07305818 · EU 2025-523823-23-00 - 2. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
- Where
- Barcelona, Pamplona, Seville
- Életkor
- 18 év to 75 év
- People
- 30 worldwide
- Run by
- Sanofi
See details and how to joinNCT06984627 - 2. fázisTaking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Badalona, Barcelona, Córdoba, Granada, Madrid, Pamplona, Sevilla
- Életkor
- 18 év to 75 év
- People
- 240 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00 - 2. fázisTaking peopleAn Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
- Where
- Seville, Valencia
- Életkor
- 18 év to 99 év
- People
- 30 worldwide
- Run by
- Amgen
See details and how to joinNCT07438405 - 2. fázisTaking peopleStudy to Assess K1-70 in Participants with Active Thyroid Eye Disease
- Where
- Barcelona, Cordoba, Granada, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Av7 Limited
See details and how to join2024-519292-26-00